Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04427384 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 1 of 54 sitesv39
  2. Site contacts updated at 1 of 54 sitesv38
  3. Study sites: 53 to 54v37
  4. Site contacts updated at 1 of 53 sitesv36
  5. Study sites: 52 to 53v35
Show 33 earlier versionsHide 33 earlier versions
  1. Study sites: 51 to 52v34
  2. Study sites: 48 to 51 Eligibility criteria expanded, about 34 wordsv33 Show 1 more changeShow less
    • Eligibility criteria expanded, about 34 words

    See this version in full on ClinicalTrials.gov ↗

  3. Site contacts updated at 27 of 48 sitesv32
  4. Study sites: 47 to 48v31
  5. Study sites: 46 to 47v30
  6. Study sites revised (46)v29 See this version in full on ClinicalTrials.gov ↗
  7. Site contacts updated at 2 of 46 sitesv28
  8. Study sites: 44 to 46v27
  9. Study sites: 43 to 44v26
  10. Study sites: 42 to 43v25
  11. Study sites revised (42)v24 See this version in full on ClinicalTrials.gov ↗
  12. Study sites: 41 to 42v23
  13. Study sites: 40 to 41v22
  14. 2 versions Re-verified since Feb 13, 2024, no change to tracked fieldsv20-v21
  15. Study sites: 39 to 40v19
  16. Study sites: 38 to 39v18
  17. Study sites: 36 to 38v17
  18. Site contacts updated at 1 of 36 sitesv16
  19. Study sites: 35 to 36v15
  20. Study sites: 34 to 35v14
  21. Study sites: 33 to 34v13
  22. Study sites: 32 to 33v12
  23. Study sites: 31 to 32v11
  24. Site contacts updated at 1 of 31 sitesv10
  25. Study sites: 29 to 31v9
  26. Study sites: 26 to 29v8
  27. Study sites: 22 to 26v7
  28. Study sites: 19 to 22v6
  29. Study sites: 9 to 19v5
  30. Study sites: 8 to 9v4
  31. Study sites: 1 to 8v3
  32. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Oct 31, 2020 to Sep 11, 2020v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 31, 2020 to Sep 11, 2020
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Trial Details
NCT Number NCT04427384
Lead Sponsor GT Medical Technologies, Inc.
Conditions Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov